No black box warning on record for Candesartan Cilexetil

As of the latest FDA labeling reviewed, Candesartan Cilexetil (CANDESARTAN CILEXETIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Candesartan Cilexetil medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Fetal Toxicity Candesartan cilexetil tablets can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and

No black box warning on record for Candesartan Cilexetil

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Fetal Toxicity Candesartan cilexetil tablets can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and

Candesartan Cilexetil Black Box Warning

No black box warning on record for Candesartan Cilexetil

Other warnings & precautions

Candesartan Cilexetil Black Box Warning

No black box warning on record for Candesartan Cilexetil

Other warnings & precautions